Skip to content

MapLight Therapeutics, Inc. MPLT Total Liabilities & Equity

Total Liabilities & Equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$200.89B+3.7%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$4.91B+33.0%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$1.61B+41.8%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$393.48M

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%
Total assets$418.8M

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$1.39B+100%
Enterprise value$1.34B

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio22.9×

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's total liabilities & equity?
MapLight Therapeutics, Inc. (MPLT) reported total liabilities & equity of $418.79M in Q1 2026.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.